The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Advanced Drainage Systems, Inc. | Common | 00790R104 | 359 | 2,884 | SH | OTR | 2,884 | 0 | 0 | ||
Aptinyx, Inc. | Common | 03836N103 | 1,997 | 5,395,996 | SH | SOLE | 5,395,996 | 0 | 0 | ||
Corvus Pharmaceuticals, Inc. | Common | 221015100 | 2,683 | 3,275,616 | SH | SOLE | 3,275,616 | 0 | 0 | ||
Fusion Pharmaceuticals, Inc. | Common | 36118A100 | 8,873 | 2,947,809 | SH | SOLE | 2,947,809 | 0 | 0 | ||
GitLab, Inc. | Common Class A | 37637K108 | 4,257 | 83,121 | SH | OTR | 83,121 | 0 | 0 | ||
Health Catalyst, Inc. | Common | 42225T107 | 331 | 34,157 | SH | SOLE | 34,157 | 0 | 0 | ||
Icosavax, Inc. | Common | 45114M109 | 10,720 | 3,392,392 | SH | SOLE | 3,392,392 | 0 | 0 | ||
Paylocity Holding Corporation | Common | 70438V106 | 143,305 | 593,200 | SH | SOLE | 593,200 | 0 | 0 | ||
Pinduoduo, Inc. | ADS | 722304102 | 6,316 | 100,926 | SH | OTR | 100,926 | 0 | 0 | ||
Q2 Holdings, Inc. | Common | 74736L109 | 25,037 | 777,562 | SH | SOLE | 777,562 | 0 | 0 | ||
Rimini Street, Inc. | Common | 76674Q107 | 109,815 | 23,565,433 | SH | SOLE | 23,565,433 | 0 | 0 | ||
Vacasa, Inc. | Common- Class A | 91854V107 | 50,741 | 16,527,901 | SH | SOLE | 16,527,901 | 0 | 0 | ||
Xpeng, Inc | ADS | 98422D105 | 631 | 52,766 | SH | OTR | 52,766 | 0 | 0 |